| Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu–Natal, South Africa KI Barnes, DN Durrheim, F Little, A Jackson, U Mehta, E Allen, SS Dlamini, ... PLoS medicine 2 (11), e330, 2005 | 369 | 2005 |
| Quality assurance of qualitative research: a review of the discourse J Reynolds, J Kizito, N Ezumah, P Mangesho, E Allen, C Chandler Health research policy and systems 9 (1), 1-10, 2011 | 206 | 2011 |
| Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta … WWARN Gametocyte Study Group teun. bousema@ radboudumc. nl kasia ... BMC medicine 14, 1-18, 2016 | 121 | 2016 |
| Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settings U Mehta, C Clerk, E Allen, M Yore, E Sevene, J Singlovic, M Petzold, ... BMC pregnancy and childbirth 12, 1-13, 2012 | 47 | 2012 |
| Safety, Tolerability, Pharmacokinetics, and Antimalarial Activity of the Novel Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048 in Healthy Volunteers P Sinxadi, C Donini, H Johnstone, G Langdon, L Wiesner, E Allen, ... Antimicrobial agents and chemotherapy 64 (4), 10.1128/aac. 01896-19, 2020 | 46 | 2020 |
| Eliciting adverse effects data from participants in clinical trials EN Allen, CIR Chandler, N Mandimika, C Leisegang, K Barnes Cochrane Database of Systematic Reviews, 2018 | 43 | 2018 |
| Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial J Raman, E Allen, L Workman, A Mabuza, H Swanepoel, G Malatje, ... Malaria Journal 18 (1), 1-13, 2019 | 33 | 2019 |
| Malaria pharmacovigilance in Africa: lessons from a pilot project in Mpumalanga Province, South Africa U Mehta, D Durrheim, A Mabuza, L Blumberg, E Allen, KI Barnes Drug safety 30, 899-910, 2007 | 30 | 2007 |
| How experiences become data: the process of eliciting adverse event, medical history and concomitant medication reports in antimalarial and antiretroviral interaction trials EN Allen, AK Mushi, IS Massawe, LS Vestergaard, M Lemnge, ... BMC medical research methodology 13 (1), 1-13, 2013 | 28 | 2013 |
| Efficacy of sulphadoxine-pyrimethamine with or without artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in southern Mozambique: a … EN Allen, F Little, T Camba, Y Cassam, J Raman, A Boulle, KI Barnes Malaria Journal 8, 1-10, 2009 | 22 | 2009 |
| Population pharmacokinetic properties of sulfadoxine and pyrimethamine: a pooled analysis to inform optimal dosing in African children with uncomplicated malaria M de Kock, J Tarning, L Workman, EN Allen, MM Tekete, AA Djimde, ... Antimicrobial agents and chemotherapy 62 (5), 10.1128/aac. 01370-17, 2018 | 19 | 2018 |
| Therapeutic efficacy of sulfadoxine-pyrimethamine for Plasmodium falciparum malaria A Mabuza, J Govere, N Mngomezulu, E Allen, A Zitha, F Mbokazi, ... South African Medical Journal 95 (5), 2005 | 19 | 2005 |
| Establishing pharmacovigilance programs in resource-limited settings: the example of treating malaria U Mehta, E Allen, KI Barnes Expert review of clinical pharmacology 3 (4), 509-525, 2010 | 18 | 2010 |
| Education and training for medicines development, regulation, and clinical research in emerging countries S Kerpel-Fronius, B Rosenkranz, E Allen, R Bass, JD Mainard, A Dodoo, ... Frontiers in pharmacology 6, 80, 2015 | 16 | 2015 |
| Evaluating harm associated with anti-malarial drugs: a survey of methods used by clinical researchers to elicit, assess and record participant-reported adverse events and … EN Allen, CIR Chandler, N Mandimika, C Pace, U Mehta, KI Barnes Malaria journal 12 (1), 1-9, 2013 | 16 | 2013 |
| Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malaria TA Anyorigiya, S Castel, K Mauff, F Atuguba, B Ogutu, A Oduro, D Dosoo, ... Malaria Journal 20, 1-15, 2021 | 12 | 2021 |
| Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data K Stepniewska, EN Allen, GS Humphreys, E Poirot, E Craig, K Kennon, ... BMC medicine 20 (1), 350, 2022 | 11 | 2022 |
| Building capability for clinical pharmacology research in sub‐Saharan Africa MM Gutierrez, G Pillai, S Felix, F Romero, KO Onyango, S Owusu‐Agyei, ... Clinical Pharmacology & Therapeutics 102 (5), 786-795, 2017 | 9 | 2017 |
| Influences on participant reporting in the World Health Organisation drugs exposure pregnancy registry; a qualitative study EN Allen, M Gomes, L Yevoo, O Egesah, C Clerk, J Byamugisha, ... BMC health services research 14, 1-11, 2014 | 9 | 2014 |
| Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data BMC medicine 20 (1), 85, 2022 | 7 | 2022 |
